ArticleWorld journal of gastrointestinal surgery2025
Risk factors of fever following endoscopic radiofrequency ablation for early esophageal squamous cell carcinoma and precancerous lesions.
Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent studies have revealed that endoscopic minimally invasive treatment of early esophageal cancer and precancerous lesions is as effective as traditional surgery and offer considerable advantages, such as minimal invasiveness, enhanced safety, lower costs, and improved quality of life after surgery.
aimTo analyze factors affecting postoperative fever in patients with early esophageal squamous cell carcinoma and precancerous lesions who underwent endoscopic radiofrequency ablation (ERFA).
methodsClinical data of 29 patients with esophageal lesions admitted to The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University between March 2022 and June 2024 were retrospectively analyzed. All patients underwent ERFA and were divided into a fever group and a non-fever group based on whether they experienced fever after surgery. The general characteristics of both groups were analyzed, and univariate analysis of variance and multivariate logistic regression were conducted to examine the factors that influence the incidence of fever in patients with early esophageal squamous cell carcinoma and precancerous lesions treated with ERFA.
resultsAmong the 29 patients with esophageal lesions treated with ERFA, 11 did not experience fever, whereas 18 (62.07%) experienced it. Univariate analysis of variance showed that the ablation length and duration of postoperative fasting were significantly different between the fever and non-fever groups (
conclusionThe incidence of fever is high in patients with early esophageal lesions treated with ERFA, which is related to the ablation length and duration of postoperative fasting. The results can guide modifications in the treatment and nursing plans for patients with esophageal lesions to reduce the risk of postoperative fever.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.